Determinants of pathological complete response to neoadjuvant chemotherapy in breast cancer: A single-institution experience.

Shalaka Joshi,Qurratulain Chougle,Jarin Noronha,Rohini Hawaldar,Nita Nair,Vaibhav Vanmali,Vani Parmar,Purvi Thakkar,Garvit Chitkara,Tanuja Shet,Rajendra A Badwe

Indian journal of cancer（2023）

引用 0|浏览2

暂无评分

摘要

Response to chemotherapy depends on molecular subtype and duration of NACT. A low rate of pCR in the HR+ subgroup of patients warrants reconsideration of neoadjuvant strategies.

查看译文

关键词

Breast cancer India,neoadjuvant chemotherapy,pathological complete response rate

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要